- Home
- MRNA vs SGI Comparison
MRNA vs SGI Comparison
Compare MRNA & SGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRNA | SGI |
|---|---|---|
| Founded | 2010 | 1846 |
| Country | United States | United States |
| Employees | N/A | 19000 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Home Furnishings |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.5B | 16.7B |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | MRNA | SGI |
|---|---|---|
| Price | $45.43 | $74.97 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 12 | 8 |
| Target Price | $34.27 | ★ $97.88 |
| AVG Volume (30 Days) | ★ 5.0M | 2.7M |
| Earning Date | 05-01-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 0.90% |
| EPS Growth | ★ 21.77 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $19,263,000,000.00 | N/A |
| Revenue This Year | $9.36 | $7.30 |
| Revenue Next Year | $15.43 | $4.99 |
| P/E Ratio | ★ N/A | $48.98 |
| Revenue Growth | ★ 4.29 | N/A |
| 52 Week Low | $22.28 | $56.15 |
| 52 Week High | $59.55 | $98.56 |
Technical Indicators
Market Signals| Indicator | MRNA | SGI |
|---|---|---|
| Relative Strength Index (RSI) | 34.56 | 41.77 |
| Support Level | $23.52 | $69.62 |
| Resistance Level | $55.36 | $75.69 |
| Average True Range (ATR) | 2.76 | 3.26 |
| MACD | -0.87 | -0.25 |
| Stochastic Oscillator | 7.21 | 5.25 |
Price Performance
Historical ComparisonAbout MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About SGI Somnigroup International Inc.
Somnigroup International Inc is a bedding company, dedicated to improving people's lives through good sleep. With superior capabilities in design, manufacturing, distribution and retail, It delivers breakthrough sleep solutions and serves the evolving needs of consumers in more than 100 countries world-wide through its fully-owned businesses Mattress Firm, Tempur Sealy North America and Tempur Sealy International. The company's portfolio includes the brand such as Tempur-Pedic, Sealy and Stearns & Foster, and its Multinational omnichannel platform enables the company to meet consumers wherever shop, offering a personal connection and innovation to provide a retail experience and tailored solutions.